Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women

Menopause

Volumn 19, Issue 11, 2012, Pages 1208-1214

  Hitchcock, Christine Laura ^a,b   Elliott, Thomas G ^a   Norman, Eric G ^a   Stajic, Vesna ^a   Teede, Helena ^b   Prior, Jerilynn C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Albumin; Blood pressure; C reactive protein; Cardiovascular risk; D dimer; Endothelial function; Fasting glucose; Hot flashes; Lipids; Night sweats; Postmenopause; Vasomotor symptoms; Waist circumference; Waist to height ratio

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; D DIMER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HEART RATE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; MENSTRUATION; NIGHT SWEAT; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VEIN OCCLUSION PLETHYSMOGRAPHY; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; RISK FACTORS; SWEATING; WAIST CIRCUMFERENCE;

EID: 84868692749     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31825541cc     Document Type: Article

References (27)

1. Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri-and postmenopausal women in the United States. Climacteric 2008;11:32-43.
2. Pinkerton JV, Stovall DW. Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk? Menopause 2009;16:219-223.
3. Pinto MMPJ, Tomlinson G, Cheung AM. Are night sweats related to bone change? A prospective population-based study in women 40-60 from the Canadian Multicentre Osteoporosis Study. Endocr Soc Abstracts 2007;P2-143.
4. Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: A longitudinal analysis. Menopause 2009;16:239-246.
5. Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI. Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:379-388.
6. Hitchcock CL, Prior JC. Oral micronized progesterone for vasomotor symptoms-a placebo-controlled randomized trial in healthy postmeno-pausal women [e-pub]. Menopause 2012.
7. Prior JC, Alojado N, McKay DW, Vigna YM. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, cross-over trial. Obstet Gyne-col 1994;83:24-28. (Pubitemid 24027375)
8. Schneider HJ, Friedrich N, Klotsche J, et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab 2010;95:1777-1785.
9. Mather KJ, Norman EG, Prior JC, Elliott TG. Preserved forearm endo-Thelial responses with acute exposure to progesterone: A randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women. J Clin Endocrinol Metab 2000;85:4644-4649. (Pubitemid 32157647)
10. Kalyan S, Hitchcock CL, Sirrs S, Pudek M, Prior JC. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovar-iectomy. Pharmacotherapy 2010;30:442-452.
11. Gast GC, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-1498.
12. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010;66:285-290.
13. Gast GC, Pop VJ, Samsioe GN, et al. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 2011;18:146-151.
14. Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Vas-omotor symptoms and mortality: the Rancho Bernardo Study. Menopause 2009;16:888-891.
15. Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women. Ann Med 2010;42:216-222.
16. Tuomikoski P, Ebert P, Groop PH, et al. Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-908.
17. Tuomikoski P, Mikkola TS, Hamalainen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes. Menopause 2010; 17:145-151.
18. Thurston RC, Santoro N, Matthews KA. Adiposity and hot flashes in midlife women: A modifying role of age. J Clin Endocrinol Metab 2011;96:E1588-E1595.
19. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434. (Pubitemid 351656746)
20. den Tonkelaar I, Seidell JC, van Noord PA. Obesity and fat distribution in relation to hot flashes in Dutch women from the DOM-project. Maturitas 1996;23:301-305. (Pubitemid 26000611)
21. Thurston RC, Sowers MR, Chang Y, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the Study of Women's Health Across the Nation. Am J Epidemiol 2008;167:78-85.
22. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.
23. Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-1206.
24. Sassarini J, Fox H, Ferrell W, Sattar N, Lumsden MA. Vascular function and cardiovascular risk factors in women with severe flushing. Clin Endocrinol 2011;74:97-103.
25. Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause 2011;18:1044-1051.
26. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-1482. (Pubitemid 28228207)
27. Szmuilowicz ED, Manson JE, Rossouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011;18:603-610.